{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:29:06Z","timestamp":1772119746927,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006239","name":"Society of nuclear medicine and molecular imaging","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006239","id-type":"DOI","asserted-by":"crossref"}]},{"name":"American Cancer Society (ACS) Research Scholar Grant","award":["RSG-15-003-01-CCE"],"award-info":[{"award-number":["RSG-15-003-01-CCE"]}]},{"name":"American Brain Tumor Association (ABTA) Research Collaborators Grant","award":["ARC1700002"],"award-info":[{"award-number":["ARC1700002"]}]},{"name":"National Brain Tumor Society (NBTS) Research Grant"},{"name":"NIH\/NCI UCLA Brain Tumor SPORE","award":["1P50CA211015-01A1"],"award-info":[{"award-number":["1P50CA211015-01A1"]}]},{"name":"NIH\/NCI UCLA Brain Tumor SPORE","award":["1P50CA211015-01A1"],"award-info":[{"award-number":["1P50CA211015-01A1"]}]},{"name":"NIH\/NCI UCLA Brain Tumor SPORE","award":["1P50CA211015-01A1"],"award-info":[{"award-number":["1P50CA211015-01A1"]}]},{"name":"NIH\/NCI UCLA Brain Tumor SPORE","award":["1P50CA211015-01A1"],"award-info":[{"award-number":["1P50CA211015-01A1"]}]},{"name":"NIH\/NCI","award":["1R21CA223757-01"],"award-info":[{"award-number":["1R21CA223757-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11060-021-03730-w","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T06:03:13Z","timestamp":1615442593000},"page":"573-582","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Preferential tumor localization in relation to 18F-FDOPA uptake for lower\u2010grade gliomas"],"prefix":"10.1007","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8050-4895","authenticated-orcid":false,"given":"Hiroyuki","family":"Tatekawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0547-1210","authenticated-orcid":false,"given":"Hiroyuki","family":"Uetani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5277-3249","authenticated-orcid":false,"given":"Akifumi","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8828-1841","authenticated-orcid":false,"given":"Jingwen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8133-2928","authenticated-orcid":false,"given":"Talia C.","family":"Oughourlian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3667-1151","authenticated-orcid":false,"given":"Issei","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2757-439X","authenticated-orcid":false,"given":"Catalina","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7265-2986","authenticated-orcid":false,"given":"Albert","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8656-7483","authenticated-orcid":false,"given":"Timothy F.","family":"Cloughesy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4064-6079","authenticated-orcid":false,"given":"Phioanh L.","family":"Nghiemphu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-0052","authenticated-orcid":false,"given":"Linda M.","family":"Liau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2622-389X","authenticated-orcid":false,"given":"Shadfar","family":"Bahri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4803-1992","authenticated-orcid":false,"given":"Whitney B.","family":"Pope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3520-9467","authenticated-orcid":false,"given":"Noriko","family":"Salamon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2764-6640","authenticated-orcid":false,"given":"Benjamin M.","family":"Ellingson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"3730_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11060-015-1798-x","volume":"123","author":"Y Wang","year":"2015","unstructured":"Wang Y, Liu S, Fan X, Li S, Wang R, Wang L, Ma J, Jiang T, Ma W (2015) Age-associated brain regions in gliomas: a volumetric analysis. J Neurooncol 123:299\u2013306. https:\/\/doi.org\/10.1007\/s11060-015-1798-x","journal-title":"J Neurooncol"},{"key":"3730_CR2","doi-asserted-by":"publisher","first-page":"e32764","DOI":"10.1371\/journal.pone.0032764","volume":"7","author":"X Ren","year":"2012","unstructured":"Ren X, Cui X, Lin S, Wang J, Jiang Z, Sui D, Li J, Wang Z (2012) Co-deletion of chromosome 1p\/19q and IDH1\/2 mutation in glioma subsets of brain tumors in Chinese patients. PLoS ONE 7:e32764. https:\/\/doi.org\/10.1371\/journal.pone.0032764","journal-title":"PLoS ONE"},{"key":"3730_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.seizure.2011.12.007","volume":"21","author":"F Stockhammer","year":"2012","unstructured":"Stockhammer F, Misch M, Helms HJ, Lengler U, Prall F, von Deimling A, Hartmann C (2012) IDH1\/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom. Seizure 21:194\u2013197. https:\/\/doi.org\/10.1016\/j.seizure.2011.12.007","journal-title":"Seizure"},{"key":"3730_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jocn.2016.05.017","volume":"34","author":"I Paldor","year":"2016","unstructured":"Paldor I, Pearce FC, Drummond KJ, Kaye AH (2016) Frontal glioblastoma multiforme may be biologically distinct from non-frontal and multilobar tumors. J Clin Neurosci 34:128\u2013132. https:\/\/doi.org\/10.1016\/j.jocn.2016.05.017","journal-title":"J Clin Neurosci"},{"key":"3730_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10143-018-1014-5","volume":"42","author":"J Zhang","year":"2019","unstructured":"Zhang J, Yao L, Peng S, Fang Y, Tang R, Liu J (2019) Correlation between glioma location and preoperative seizures: a systematic review and meta-analysis. Neurosurg Rev 42:603\u2013618. https:\/\/doi.org\/10.1007\/s10143-018-1014-5","journal-title":"Neurosurg Rev"},{"key":"3730_CR6","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1200\/JCO.2007.13.9337","volume":"26","author":"JS Smith","year":"2008","unstructured":"Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338\u20131345. https:\/\/doi.org\/10.1200\/JCO.2007.13.9337","journal-title":"J Clin Oncol"},{"key":"3730_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.nicl.2016.03.007","volume":"12","author":"M Bilello","year":"2016","unstructured":"Bilello M, Akbari H, Da X, Pisapia JM, Mohan S, Wolf RL, O\u2019Rourke DM, Martinez-Lage M, Davatzikos C (2016) Population-based MRI atlases of spatial distribution are specific to patient and tumor characteristics in glioblastoma. Neuroimage Clin 12:34\u201340. https:\/\/doi.org\/10.1016\/j.nicl.2016.03.007","journal-title":"Neuroimage Clin"},{"key":"3730_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1148\/radiol.2019190491","volume":"293","author":"A Roux","year":"2019","unstructured":"Roux A, Roca P, Edjlali M, Sato K, Zanello M, Dezamis E, Gori P, Lion S, Fleury A, Dhermain F, Meder JF, Chretien F, Lechapt E, Varlet P, Oppenheim C, Pallud J (2019) MRI atlas of IDH wild-type supratentorial glioblastoma: probabilistic maps of phenotype, management, and outcomes. Radiology 293:633\u2013643. https:\/\/doi.org\/10.1148\/radiol.2019190491","journal-title":"Radiology"},{"key":"3730_CR9","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.neuroimage.2011.09.076","volume":"59","author":"BM Ellingson","year":"2012","unstructured":"Ellingson BM, Cloughesy TF, Pope WB, Zaw TM, Phillips H, Lalezari S, Nghiemphu PL, Ibrahim H, Naeini KM, Harris RJ, Lai A (2012) Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: a radiographic study in 358 de novo human glioblastomas. Neuroimage 59:908\u2013916. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.09.076","journal-title":"Neuroimage"},{"key":"3730_CR10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3174\/ajnr.A3253","volume":"34","author":"BM Ellingson","year":"2013","unstructured":"Ellingson BM, Lai A, Harris RJ, Selfridge JM, Yong WH, Das K, Pope WB, Nghiemphu PL, Vinters HV, Liau LM, Mischel PS, Cloughesy TF (2013) Probabilistic radiographic atlas of glioblastoma phenotypes. AJNR Am J Neuroradiol 34:533\u2013540. https:\/\/doi.org\/10.3174\/ajnr.A3253","journal-title":"AJNR Am J Neuroradiol"},{"key":"3730_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/neuonc\/not199","volume":"16","author":"C Kratochwil","year":"2014","unstructured":"Kratochwil C, Combs SE, Leotta K, Afshar-Oromieh A, Rieken S, Debus J, Haberkorn U, Giesel FL (2014) Intra-individual comparison of (1)(8)F-FET and (1)(8)F-DOPA in PET imaging of recurrent brain tumors. Neuro Oncol 16:434\u2013440. https:\/\/doi.org\/10.1093\/neuonc\/not199","journal-title":"Neuro Oncol"},{"key":"3730_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00259-016-3494-2","volume":"44","author":"SH Poulsen","year":"2017","unstructured":"Poulsen SH, Urup T, Grunnet K, Christensen IJ, Larsen VA, Jensen ML, Af Rosenschold PM, Poulsen HS, Law I (2017) The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma. Eur J Nucl Med Mol Imaging 44:373\u2013381. https:\/\/doi.org\/10.1007\/s00259-016-3494-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3730_CR13","first-page":"5117","volume":"35","author":"V Villani","year":"2015","unstructured":"Villani V, Carapella CM, Chiaravalloti A, Terrenato I, Piludu F, Vidiri A, Schillaci O, Floris R, Marzi S, Fabi A, Pace A (2015) The role of PET [18F]FDOPA in evaluating low-grade glioma. Anticancer Res 35:5117\u20135122","journal-title":"Anticancer Res"},{"key":"3730_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11060-018-2877-6","volume":"139","author":"CB Patel","year":"2018","unstructured":"Patel CB, Fazzari E, Chakhoyan A, Yao J, Raymond C, Nguyen H, Manoukian J, Nguyen N, Pope W, Cloughesy TF, Nghiemphu PL, Czernin J, Lai A, Ellingson BM (2018) (18)F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naive gliomas: a cross-sectional study. J Neurooncol 139:399\u2013409. https:\/\/doi.org\/10.1007\/s11060-018-2877-6","journal-title":"J Neurooncol"},{"key":"3730_CR15","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1007\/s00259-017-3668-6","volume":"44","author":"A Verger","year":"2017","unstructured":"Verger A, Metellus P, Sala Q, Colin C, Bialecki E, Taieb D, Chinot O, Figarella-Branger D, Guedj E (2017) IDH mutation is paradoxically associated with higher (18)F-FDOPA PET uptake in diffuse grade II and grade III gliomas. Eur J Nucl Med Mol Imaging 44:1306\u20131311. https:\/\/doi.org\/10.1007\/s00259-017-3668-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3730_CR16","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00259-019-04509-y","volume":"47","author":"M Ginet","year":"2020","unstructured":"Ginet M, Zaragori T, Marie PY, Roch V, Gauchotte G, Rech F, Blonski M, Lamiral Z, Taillandier L, Imbert L, Verger A (2020) Integration of dynamic parameters in the analysis of (18)F-FDopa PET imaging improves the prediction of molecular features of gliomas. Eur J Nucl Med Mol Imaging 47:1381\u20131390. https:\/\/doi.org\/10.1007\/s00259-019-04509-y","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3730_CR17","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00701-018-3563-3","volume":"160","author":"O Naslund","year":"2018","unstructured":"Naslund O, Smits A, Forander P, Laesser M, Bartek J Jr, Gempt J, Liljegren A, Daxberg EL, Jakola AS (2018) Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications. Acta Neurochir (Wien) 160:1451\u20131460. https:\/\/doi.org\/10.1007\/s00701-018-3563-3","journal-title":"Acta Neurochir (Wien)"},{"key":"3730_CR18","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1007\/s11307-019-01357-y","volume":"21","author":"O Kertels","year":"2019","unstructured":"Kertels O, Kessler AF, Mihovilovic MI, Stolzenburg A, Linsenmann T, Samnick S, Brandlein S, Monoranu CM, Ernestus RI, Buck AK, Lohr M, Lapa C (2019) Prognostic value of O-(2-[(18)F]Fluoroethyl)-L-tyrosine PET\/CT in newly diagnosed WHO 2016 Grade II and III glioma. Mol Imaging Biol 21:1174\u20131181. https:\/\/doi.org\/10.1007\/s11307-019-01357-y","journal-title":"Mol Imaging Biol"},{"key":"3730_CR19","doi-asserted-by":"publisher","first-page":"20170803","DOI":"10.1259\/bjr.20170803","volume":"91","author":"S Isal","year":"2018","unstructured":"Isal S, Gauchotte G, Rech F, Blonski M, Planel S, Chawki MB, Karcher G, Marie PY, Taillandier L, Verger A (2018) A high (18)F-FDOPA uptake is associated with a slow growth rate in diffuse Grade II-III gliomas. Br J Radiol 91:20170803. https:\/\/doi.org\/10.1259\/bjr.20170803","journal-title":"Br J Radiol"},{"key":"3730_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12149-018-01328-3","volume":"33","author":"F Cicone","year":"2019","unstructured":"Cicone F, Carideo L, Scaringi C, Arcella A, Giangaspero F, Scopinaro F, Minniti G (2019) (18)F-DOPA uptake does not correlate with IDH mutation status and 1p\/19q co-deletion in glioma. Ann Nucl Med 33:295\u2013302. https:\/\/doi.org\/10.1007\/s12149-018-01328-3","journal-title":"Ann Nucl Med"},{"key":"3730_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11060-020-03407-w","volume":"147","author":"TC Oughourlian","year":"2020","unstructured":"Oughourlian TC, Yao J, Schlossman J, Raymond C, Ji M, Tatekawa H, Salamon N, Pope WB, Czernin J, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM (2020) Rate of change in maximum (18)F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas. J Neurooncol 147:135\u2013145. https:\/\/doi.org\/10.1007\/s11060-020-03407-w","journal-title":"J Neurooncol"},{"key":"3730_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2967\/jnumed.120.247411","volume":"62","author":"H Tatekawa","year":"2020","unstructured":"Tatekawa H, Hagiwara A, Yao J, Oughourlian TC, Ueda I, Uetani H, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM (2020) Voxel-wise and patient-wise correlation of 18F-FDOPA PET, rCBV, and ADC in treatment-na\u00efve diffuse gliomas with different molecular subtypes. J Nucl Med 62:319\u2013325","journal-title":"J Nucl Med"},{"key":"3730_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11060-020-03613-6","volume":"149","author":"H Tatekawa","year":"2020","unstructured":"Tatekawa H, Hagiwara A, Uetani H, Yao J, Oughourlian TC, Bahri S, Wang C, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM (2020) Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-na\u00efve diffuse gliomas. J Neurooncol 149:337\u2013346. https:\/\/doi.org\/10.1007\/s11060-020-03613-6","journal-title":"J Neurooncol"},{"key":"3730_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0969-8051(95)02037-3","volume":"23","author":"A Bishop","year":"1996","unstructured":"Bishop A, Satyamurthy N, Bida G, Hendry G, Phelps M, Barrio JR (1996) Proton irradiation of [18O]O2: production of [18F]F2 and [18F]F2 + [18F] OF2. Nucl Med Biol 23:189\u2013199. https:\/\/doi.org\/10.1016\/0969-8051(95)02037-3","journal-title":"Nucl Med Biol"},{"key":"3730_CR25","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/0883-2889(92)90217-3","volume":"43","author":"M Namavari","year":"1992","unstructured":"Namavari M, Bishop A, Satyamurthy N, Bida G, Barrio JR (1992) Regioselective radiofluorodestannylation with [18F]F2 and [18F]CH3COOF: a high yield synthesis of 6-[18F]Fluoro-L-dopa. Int J Rad Appl Instrum A 43:989\u2013996. https:\/\/doi.org\/10.1016\/0883-2889(92)90217-3","journal-title":"Int J Rad Appl Instrum A"},{"key":"3730_CR26","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1118\/1.598392","volume":"25","author":"PE Kinahan","year":"1998","unstructured":"Kinahan PE, Townsend DW, Beyer T, Sashin D (1998) Attenuation correction for a combined 3D PET\/CT scanner. Med Phys 25:2046\u20132053. https:\/\/doi.org\/10.1118\/1.598392","journal-title":"Med Phys"},{"key":"3730_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1109\/42.925290","volume":"20","author":"J Nuyts","year":"2001","unstructured":"Nuyts J, Michel C, Dupont P (2001) Maximum-likelihood expectation-maximization reconstruction of sinograms with arbitrary noise distribution using NEC-transformations. IEEE Trans Med Imaging 20:365\u2013375. https:\/\/doi.org\/10.1109\/42.925290","journal-title":"IEEE Trans Med Imaging"},{"key":"3730_CR28","first-page":"1431","volume":"45","author":"JA Thie","year":"2004","unstructured":"Thie JA (2004) Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med 45:1431\u20131434","journal-title":"J Nucl Med"},{"key":"3730_CR29","first-page":"904","volume":"47","author":"W Chen","year":"2006","unstructured":"Chen W, Silverman DH, Delaloye S, Czernin J, Kamdar N, Pope W, Satyamurthy N, Schiepers C, Cloughesy T (2006) 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med 47:904\u2013911","journal-title":"J Nucl Med"},{"key":"3730_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1148\/radiol.13131305","volume":"271","author":"BM Ellingson","year":"2014","unstructured":"Ellingson BM, Kim HJ, Woodworth DC, Pope WB, Cloughesy JN, Harris RJ, Lai A, Nghiemphu PL, Cloughesy TF (2014) Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. Radiology 271:200\u2013210. https:\/\/doi.org\/10.1148\/radiol.13131305","journal-title":"Radiology"},{"key":"3730_CR31","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/neuonc\/not198","volume":"16","author":"AN Tran","year":"2014","unstructured":"Tran AN, Lai A, Li S, Pope WB, Teixeira S, Harris RJ, Woodworth DC, Nghiemphu PL, Cloughesy TF, Ellingson BM (2014) Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry. Neuro Oncol 16:414\u2013420. https:\/\/doi.org\/10.1093\/neuonc\/not198","journal-title":"Neuro Oncol"},{"key":"3730_CR32","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00259-018-4207-9","volume":"46","author":"I Law","year":"2019","unstructured":"Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, la Fougere C, Langen KJ, Lopci E, Lowe V, McConathy J, Quick HH, Sattler B, Schuster DM, Tonn JC, Weller M (2019) Joint EANM\/EANO\/RANO practice guidelines\/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0. Eur J Nucl Med Mol Imaging 46:540\u2013557. https:\/\/doi.org\/10.1007\/s00259-018-4207-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3730_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1109\/42.750253","volume":"18","author":"ET Bullmore","year":"1999","unstructured":"Bullmore ET, Suckling J, Overmeyer S, Rabe-Hesketh S, Taylor E, Brammer MJ (1999) Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans Med Imaging 18:32\u201342. https:\/\/doi.org\/10.1109\/42.750253","journal-title":"IEEE Trans Med Imaging"},{"key":"3730_CR34","doi-asserted-by":"publisher","first-page":"e0144200","DOI":"10.1371\/journal.pone.0144200","volume":"11","author":"S Parisot","year":"2016","unstructured":"Parisot S, Darlix A, Baumann C, Zouaoui S, Yordanova Y, Blonski M, Rigau V, Chemouny S, Taillandier L, Bauchet L, Duffau H, Paragios N (2016) A probabilistic atlas of diffuse WHO Grade II glioma locations in the brain. PLoS ONE 11:e0144200. https:\/\/doi.org\/10.1371\/journal.pone.0144200","journal-title":"PLoS ONE"},{"key":"3730_CR35","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1002\/cncr.20297","volume":"100","author":"H Duffau","year":"2004","unstructured":"Duffau H, Capelle L (2004) Preferential brain locations of low-grade gliomas. Cancer 100:2622\u20132626. https:\/\/doi.org\/10.1002\/cncr.20297","journal-title":"Cancer"},{"key":"3730_CR36","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1212\/wnl.57.5.871","volume":"57","author":"A Krainik","year":"2001","unstructured":"Krainik A, Leh\u00e9ricy S, Duffau H, Vlaicu M, Poupon F, Capelle L, Cornu P, Clemenceau S, Sahel M, Valery CA, Boch AL, Mangin JF, Bihan DL, Marsault C (2001) Role of the supplementary motor area in motor deficit following medial frontal lobe surgery. Neurology 57:871\u2013878. https:\/\/doi.org\/10.1212\/wnl.57.5.871","journal-title":"Neurology"},{"key":"3730_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10143-015-0675-6","volume":"39","author":"GL Lima","year":"2016","unstructured":"Lima GL, Zanello M, Mandonnet E, Taillandier L, Pallud J, Duffau H (2016) Incidental diffuse low-grade gliomas: from early detection to preventive neuro-oncological surgery. Neurosurg Rev 39:377\u2013384. https:\/\/doi.org\/10.1007\/s10143-015-0675-6","journal-title":"Neurosurg Rev"},{"key":"3730_CR38","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3171\/2011.9.JNS111068","volume":"116","author":"MB Potts","year":"2012","unstructured":"Potts MB, Smith JS, Molinaro AM, Berger MS (2012) Natural history and surgical management of incidentally discovered low-grade gliomas. J Neurosurg 116:365\u2013372. https:\/\/doi.org\/10.3171\/2011.9.JNS111068","journal-title":"J Neurosurg"},{"key":"3730_CR39","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/ana.22106","volume":"68","author":"J Pallud","year":"2010","unstructured":"Pallud J, Fontaine D, Duffau H, Mandonnet E, Sanai N, Taillandier L, Peruzzi P, Guillevin R, Bauchet L, Bernier V, Baron MH, Guyotat J, Capelle L (2010) Natural history of incidental World Health Organization grade II gliomas. Ann Neurol 68:727\u2013733. https:\/\/doi.org\/10.1002\/ana.22106","journal-title":"Ann Neurol"},{"key":"3730_CR40","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1007\/s00701-013-1886-7","volume":"155","author":"J Pallud","year":"2013","unstructured":"Pallud J, Capelle L, Taillandier L, Badoual M, Duffau H, Mandonnet E (2013) The silent phase of diffuse low-grade gliomas. Is it when we missed the action? Acta Neurochir (Wien) 155:2237\u20132242. https:\/\/doi.org\/10.1007\/s00701-013-1886-7","journal-title":"Acta Neurochir (Wien)"},{"key":"3730_CR41","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.2967\/jnumed.115.171033","volume":"57","author":"M Unterrainer","year":"2016","unstructured":"Unterrainer M, Schweisthal F, Suchorska B, Wenter V, Schmid-Tannwald C, Fendler WP, Schuller U, Bartenstein P, Tonn JC, Albert NL (2016) Serial 18F-FET PET imaging of primarily 18F-FET-negative glioma: does it make sense? J Nucl Med 57:1177\u20131182. https:\/\/doi.org\/10.2967\/jnumed.115.171033","journal-title":"J Nucl Med"},{"key":"3730_CR42","doi-asserted-by":"publisher","first-page":"e951","DOI":"10.1016\/j.wneu.2018.07.107","volume":"118","author":"A Mishra","year":"2018","unstructured":"Mishra A, John AP, Shukla D, Sathyaprabha TN, Devi BI (2018) Autonomic function in insular glioma: an exploratory study. World Neurosurg 118:e951\u2013e955. https:\/\/doi.org\/10.1016\/j.wneu.2018.07.107","journal-title":"World Neurosurg"},{"key":"3730_CR43","doi-asserted-by":"publisher","first-page":"e1902","DOI":"10.1212\/WNL.0000000000006517","volume":"91","author":"F Almairac","year":"2018","unstructured":"Almairac F, Duffau H, Herbet G (2018) Contralesional macrostructural plasticity of the insular cortex in patients with glioma: a VBM study. Neurology 91:e1902\u2013e1908. https:\/\/doi.org\/10.1212\/WNL.0000000000006517","journal-title":"Neurology"},{"key":"3730_CR44","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3171\/2013.1.JNS121","volume":"118","author":"L Capelle","year":"2013","unstructured":"Capelle L, Fontaine D, Mandonnet E, Taillandier L, Golmard JL, Bauchet L, Pallud J, Peruzzi P, Baron MH, Kujas M, Guyotat J, Guillevin R, Frenay M, Taillibert S, Colin P, Rigau V, Vandenbos F, Pinelli C, Duffau H, French Reseau d\u2019Etude des G (2013) Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article. J Neurosurg 118:1157\u20131168. https:\/\/doi.org\/10.3171\/2013.1.JNS121","journal-title":"J Neurosurg"},{"key":"3730_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0360-3016(93)90203-8","volume":"26","author":"JR Simpson","year":"1993","unstructured":"Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS et al (1993) Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26:239\u2013244. https:\/\/doi.org\/10.1016\/0360-3016(93)90203-8","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3730_CR46","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1126\/science.1110324","volume":"308","author":"T Sun","year":"2005","unstructured":"Sun T, Patoine C, Abu-Khalil A, Visvader J, Sum E, Cherry TJ, Orkin SH, Geschwind DH, Walsh CA (2005) Early asymmetry of gene transcription in embryonic human left and right cerebral cortex. Science 308:1794\u20131798. https:\/\/doi.org\/10.1126\/science.1110324","journal-title":"Science"},{"key":"3730_CR47","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.neurobiolaging.2008.05.005","volume":"31","author":"Y Kumakura","year":"2010","unstructured":"Kumakura Y, Vernaleken I, Buchholz HG, Borghammer P, Danielsen E, Gr\u00fcnder G, Heinz A, Bartenstein P, Cumming P (2010) Age-dependent decline of steady state dopamine storage capacity of human brain: an FDOPA PET study. Neurobiol Aging 31:447\u2013463. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.05.005","journal-title":"Neurobiol Aging"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03730-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-021-03730-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03730-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T13:19:24Z","timestamp":1619702364000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-021-03730-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["3730"],"URL":"https:\/\/doi.org\/10.1007\/s11060-021-03730-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-186583\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"assertion":[{"value":"18 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"Ellingson\u2014Advisory Board\u2014Hoffman La-Roche; Siemens; Nativis; Medicenna; MedQIA; Bristol-Myers Squibb; Imaging Endpoints; Agios. Paid Consultant\u2014Nativis; MedQIA; Siemens; Hoffman La-Roche; Imaging Endpoints; Medicenna; Agios. Grant Funding\u2014Hoffman La-Roche; Siemens; Agios; Janssen. Ellingson also holds a patent on this technology (US Patent #15\/577,664; International PCT\/US2016\/034886). Cloughesy\u2014Advisory Board\u2014Roche\/ Genentech, Amgen, Tocagen, NewGen, LPath, Proximagen, Celgene, Vascular Biogenics Ltd, Insys, Agios, Cortice Bioscience, Pfizer, Human Longevity, BMS, Merck, Notable Lab, MedQIA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all individual participants to have their imaging, clinical, and molecular data included in our research database (IRB IRB#10-000655).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}